442 related articles for article (PubMed ID: 32027948)
1. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
2. RHEX, a novel regulator of human erythroid progenitor cell expansion and erythroblast development.
Verma R; Su S; McCrann DJ; Green JM; Leu K; Young PR; Schatz PJ; Silva JC; Stokes MP; Wojchowski DM
J Exp Med; 2014 Aug; 211(9):1715-22. PubMed ID: 25092874
[TBL] [Abstract][Full Text] [Related]
3. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
4. Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis.
Held MA; Greenfest-Allen E; Jachimowicz E; Stoeckert CJ; Stokes MP; Wood AW; Wojchowski DM
Exp Hematol; 2020 Apr; 84():29-44. PubMed ID: 32259549
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
[TBL] [Abstract][Full Text] [Related]
6. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
Ueda F; Tago K; Tamura H; Funakoshi-Tago M
J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
[TBL] [Abstract][Full Text] [Related]
7. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase plays an essential role in the erythropoietin-dependent proliferation of CTLL-2 cells.
Sakamoto H; Kitamura T; Yoshimura A
J Biol Chem; 2000 Nov; 275(46):35857-62. PubMed ID: 10960479
[TBL] [Abstract][Full Text] [Related]
10. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
Sathyanarayana P; Dev A; Pradeep A; Ufkin M; Licht JD; Wojchowski DM
Blood; 2012 Jun; 119(23):5522-31. PubMed ID: 22508938
[TBL] [Abstract][Full Text] [Related]
11. STAT5 as a Key Protein of Erythropoietin Signalization.
Tóthová Z; Tomc J; Debeljak N; Solár P
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281163
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic cell phosphatase negatively regulates erythropoietin-induced hemoglobinization in erythroleukemic SKT6 cells.
Sharlow ER; Pacifici R; Crouse J; Batac J; Todokoro K; Wojchowski DM
Blood; 1997 Sep; 90(6):2175-87. PubMed ID: 9310468
[TBL] [Abstract][Full Text] [Related]
13. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
14. Association of JAK2 and STAT5 with erythropoietin receptors. Role of receptor phosphorylation in erythropoietin signal transduction.
Sawyer ST; Penta K
J Biol Chem; 1996 Dec; 271(50):32430-7. PubMed ID: 8943308
[TBL] [Abstract][Full Text] [Related]
15. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
16. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.
Sasaki A; Yasukawa H; Shouda T; Kitamura T; Dikic I; Yoshimura A
J Biol Chem; 2000 Sep; 275(38):29338-47. PubMed ID: 10882725
[TBL] [Abstract][Full Text] [Related]
17. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor.
Miura Y; Miura O; Ihle JN; Aoki N
J Biol Chem; 1994 Nov; 269(47):29962-9. PubMed ID: 7961995
[TBL] [Abstract][Full Text] [Related]
18. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
Fukumoto T; Kubota Y; Kitanaka A; Yamaoka G; Ohara-Waki F; Imataki O; Ohnishi H; Ishida T; Tanaka T
Cell Signal; 2009 Dec; 21(12):1775-83. PubMed ID: 19665053
[TBL] [Abstract][Full Text] [Related]
19. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin and Friend virus gp55 activate different JAK/STAT pathways through the erythropoietin receptor in erythroid cells.
Yamamura Y; Senda H; Kageyama Y; Matsuzaki T; Noda M; Ikawa Y
Mol Cell Biol; 1998 Mar; 18(3):1172-80. PubMed ID: 9488432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]